Form D Explorer

Inspect source fieldsReport a record issue

Form D — Odyssey Therapeutics, Inc.

0001104659-25-118426 · filed Dec 4, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry
Biotechnology
Exemptions
Rule 506(b)
Reported offering amount
$214,025,200
Reported amount sold
$214,025,200
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Odyssey Therapeutics, Inc.
CIK
1882782
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
2021
Address
51 SLEEPER STREET
BOSTON, Massachusetts 02210
Phone
617-865-9628

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗